Logo image of MARR.MI

MARR SPA (MARR.MI) Stock Fundamental Analysis

BIT:MARR - Euronext Milan - IT0003428445 - Common Stock - Currency: EUR

10.12  -0.04 (-0.39%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MARR. MARR was compared to 26 industry peers in the Consumer Staples Distribution & Retail industry. MARR has only an average score on both its financial health and profitability. MARR has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year MARR was profitable.
MARR had a positive operating cash flow in the past year.
Of the past 5 years MARR 4 years were profitable.
MARR had a positive operating cash flow in 4 of the past 5 years.
MARR.MI Yearly Net Income VS EBIT VS OCF VS FCFMARR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

1.2 Ratios

MARR has a Return On Assets of 5.31%. This is in the better half of the industry: MARR outperforms 72.00% of its industry peers.
With a decent Return On Equity value of 21.31%, MARR is doing good in the industry, outperforming 72.00% of the companies in the same industry.
The Return On Invested Capital of MARR (12.82%) is better than 76.00% of its industry peers.
MARR had an Average Return On Invested Capital over the past 3 years of 6.33%. This is below the industry average of 9.21%.
The last Return On Invested Capital (12.82%) for MARR is above the 3 year average (6.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.31%
ROE 21.31%
ROIC 12.82%
ROA(3y)3.07%
ROA(5y)3.02%
ROE(3y)10.36%
ROE(5y)9.99%
ROIC(3y)6.33%
ROIC(5y)6.28%
MARR.MI Yearly ROA, ROE, ROICMARR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 2.30%, MARR is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
MARR's Profit Margin has declined in the last couple of years.
The Operating Margin of MARR (4.06%) is better than 72.00% of its industry peers.
MARR's Operating Margin has declined in the last couple of years.
MARR has a worse Gross Margin (8.35%) than 92.00% of its industry peers.
In the last couple of years the Gross Margin of MARR has remained more or less at the same level.
Industry RankSector Rank
OM 4.06%
PM (TTM) 2.3%
GM 8.35%
OM growth 3Y372.63%
OM growth 5Y-7.63%
PM growth 3YN/A
PM growth 5Y-11.21%
GM growth 3Y5.26%
GM growth 5Y1.49%
MARR.MI Yearly Profit, Operating, Gross MarginsMARR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

6

2. Health

2.1 Basic Checks

MARR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
MARR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MARR has less shares outstanding
Compared to 1 year ago, MARR has a worse debt to assets ratio.
MARR.MI Yearly Shares OutstandingMARR.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
MARR.MI Yearly Total Debt VS Total AssetsMARR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.58 indicates that MARR is not in any danger for bankruptcy at the moment.
MARR has a Altman-Z score of 3.58. This is in the better half of the industry: MARR outperforms 68.00% of its industry peers.
MARR has a debt to FCF ratio of 6.64. This is a slightly negative value and a sign of low solvency as MARR would need 6.64 years to pay back of all of its debts.
MARR has a Debt to FCF ratio of 6.64. This is comparable to the rest of the industry: MARR outperforms 56.00% of its industry peers.
MARR has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.01, MARR perfoms like the industry average, outperforming 52.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 6.64
Altman-Z 3.58
ROIC/WACC1.99
WACC6.44%
MARR.MI Yearly LT Debt VS Equity VS FCFMARR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

MARR has a Current Ratio of 1.47. This is a normal value and indicates that MARR is financially healthy and should not expect problems in meeting its short term obligations.
MARR has a Current ratio of 1.47. This is amongst the best in the industry. MARR outperforms 88.00% of its industry peers.
A Quick Ratio of 1.08 indicates that MARR should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.08, MARR belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.08
MARR.MI Yearly Current Assets VS Current LiabilitesMARR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.00% over the past year.
The Earnings Per Share has been decreasing by -7.21% on average over the past years.
The Revenue has decreased by -0.02% in the past year.
The Revenue has been growing slightly by 4.51% on average over the past years.
EPS 1Y (TTM)15%
EPS 3YN/A
EPS 5Y-7.21%
EPS Q2Q%-13.32%
Revenue 1Y (TTM)-0.02%
Revenue growth 3Y24.64%
Revenue growth 5Y4.51%
Sales Q2Q%-0.52%

3.2 Future

MARR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.27% yearly.
MARR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.59% yearly.
EPS Next Y-8.21%
EPS Next 2Y3.63%
EPS Next 3Y5.27%
EPS Next 5YN/A
Revenue Next Year-0.23%
Revenue Next 2Y1.24%
Revenue Next 3Y2.04%
Revenue Next 5Y3.59%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MARR.MI Yearly Revenue VS EstimatesMARR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 500M 1B 1.5B 2B 2.5B
MARR.MI Yearly EPS VS EstimatesMARR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.02, the valuation of MARR can be described as very reasonable.
Based on the Price/Earnings ratio, MARR is valued a bit cheaper than 80.00% of the companies in the same industry.
MARR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.62.
A Price/Forward Earnings ratio of 13.17 indicates a correct valuation of MARR.
The rest of the industry has a similar Price/Forward Earnings ratio as MARR.
MARR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.70.
Industry RankSector Rank
PE 10.02
Fwd PE 13.17
MARR.MI Price Earnings VS Forward Price EarningsMARR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MARR indicates a somewhat cheap valuation: MARR is cheaper than 76.00% of the companies listed in the same industry.
MARR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 9.34
EV/EBITDA 6.37
MARR.MI Per share dataMARR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.63%
EPS Next 3Y5.27%

6

5. Dividend

5.1 Amount

MARR has a Yearly Dividend Yield of 5.94%, which is a nice return.
Compared to an average industry Dividend Yield of 3.93, MARR pays a better dividend. On top of this MARR pays more dividend than 84.00% of the companies listed in the same industry.
MARR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 5.94%

5.2 History

The dividend of MARR decreases each year by -12.34%.
Dividend Growth(5Y)-12.34%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

MARR pays out 56.82% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP56.82%
EPS Next 2Y3.63%
EPS Next 3Y5.27%
MARR.MI Yearly Income VS Free CF VS DividendMARR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M 100M
MARR.MI Dividend Payout.MARR.MI Dividend Payout, showing the Payout Ratio.MARR.MI Dividend Payout.PayoutRetained Earnings

MARR SPA

BIT:MARR (2/24/2025, 9:39:00 AM)

10.12

-0.04 (-0.39%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)11-14 2024-11-14
Earnings (Next)03-14 2025-03-14/amc
Inst Owners24.76%
Inst Owner ChangeN/A
Ins Owners50.42%
Ins Owner ChangeN/A
Market Cap673.28M
Analysts81.82
Price Target13.12 (29.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.94%
Yearly Dividend0.38
Dividend Growth(5Y)-12.34%
DP56.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-12.53%
EPS NY rev (3m)-12.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.76%
Valuation
Industry RankSector Rank
PE 10.02
Fwd PE 13.17
P/S 0.22
P/FCF 9.34
P/OCF 7.22
P/B 2.06
P/tB 4.32
EV/EBITDA 6.37
EPS(TTM)1.01
EY9.98%
EPS(NY)0.77
Fwd EY7.59%
FCF(TTM)1.08
FCFY10.71%
OCF(TTM)1.4
OCFY13.84%
SpS45.54
BVpS4.9
TBVpS2.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.31%
ROE 21.31%
ROCE 18.18%
ROIC 12.82%
ROICexc 19.6%
ROICexgc 31.85%
OM 4.06%
PM (TTM) 2.3%
GM 8.35%
FCFM 2.38%
ROA(3y)3.07%
ROA(5y)3.02%
ROE(3y)10.36%
ROE(5y)9.99%
ROIC(3y)6.33%
ROIC(5y)6.28%
ROICexc(3y)9.52%
ROICexc(5y)9.48%
ROICexgc(3y)15.3%
ROICexgc(5y)15.59%
ROCE(3y)8.98%
ROCE(5y)8.9%
ROICexcg growth 3Y430.63%
ROICexcg growth 5Y-8.98%
ROICexc growth 3Y444.88%
ROICexc growth 5Y-7.73%
OM growth 3Y372.63%
OM growth 5Y-7.63%
PM growth 3YN/A
PM growth 5Y-11.21%
GM growth 3Y5.26%
GM growth 5Y1.49%
F-Score6
Asset Turnover2.32
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 6.64
Debt/EBITDA 2.27
Cap/Depr 98.76%
Cap/Sales 0.7%
Interest Coverage 250
Cash Conversion 64.53%
Profit Quality 103.67%
Current Ratio 1.47
Quick Ratio 1.08
Altman-Z 3.58
F-Score6
WACC6.44%
ROIC/WACC1.99
Cap/Depr(3y)86.16%
Cap/Depr(5y)82.06%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15%
EPS 3YN/A
EPS 5Y-7.21%
EPS Q2Q%-13.32%
EPS Next Y-8.21%
EPS Next 2Y3.63%
EPS Next 3Y5.27%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.02%
Revenue growth 3Y24.64%
Revenue growth 5Y4.51%
Sales Q2Q%-0.52%
Revenue Next Year-0.23%
Revenue Next 2Y1.24%
Revenue Next 3Y2.04%
Revenue Next 5Y3.59%
EBIT growth 1Y45.19%
EBIT growth 3Y489.08%
EBIT growth 5Y-3.46%
EBIT Next Year43.56%
EBIT Next 3Y18.52%
EBIT Next 5YN/A
FCF growth 1Y61.19%
FCF growth 3Y33.9%
FCF growth 5Y-4.22%
OCF growth 1Y55.26%
OCF growth 3Y30.07%
OCF growth 5Y3.45%